Terms: = Brain cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Treatment
12 results:
1. Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective.
Daisy Precilla S; Kuduvalli SS; Angeline Praveena E; Thangavel S; Anitha TS
Life Sci; 2022 Jul; 301():120609. PubMed ID: 35526592
[TBL] [Abstract] [Full Text] [Related]
2. Metachronous Skull Base Paraganglioma Surgical Management: 2-Dimensional Operative Video.
Ibn Essayed W; Al-Mefty O
Oper Neurosurg (Hagerstown); 2021 Oct; 21(5):E427-E428. PubMed ID: 34293168
[TBL] [Abstract] [Full Text] [Related]
3. Succinate Mediates Tumorigenic Effects
Matlac DM; Hadrava Vanova K; Bechmann N; Richter S; Folberth J; Ghayee HK; Ge GB; Abunimer L; Wesley R; Aherrahrou R; Dona M; Martínez-Montes ÁM; Calsina B; Merino MJ; Schwaninger M; Deen PMT; Zhuang Z; Neuzil J; Pacak K; Lehnert H; Fliedner SMJ
Front Endocrinol (Lausanne); 2021; 12():589451. PubMed ID: 33776908
[TBL] [Abstract] [Full Text] [Related]
4. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
[TBL] [Abstract] [Full Text] [Related]
5. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an sdhd mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of breast cancer subtypes in elderly patients.
Bergen ES; Tichy C; Berghoff AS; Rudas M; Dubsky P; Bago-Horvath Z; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
Breast Cancer Res Treat; 2016 May; 157(1):91-9. PubMed ID: 27107570
[TBL] [Abstract] [Full Text] [Related]
7. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract] [Full Text] [Related]
8. Hereditary paraganglioma syndrome associated with sdhd gene mutations: a patient with multicentric presentation treated with radiotherapy. Case report.
Garibaldi E; Bresciani S; Panaia R; Delmastro E; Malinverni G; Gabriele P
Tumori; 2011; 97(2):214-20. PubMed ID: 21617718
[TBL] [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract] [Full Text] [Related]
11. A model using radiation and plasmid-mediated tumor necrosis factor-alpha gene therapy for treatment of glioblastomas.
Baher AG; Andres ML; Folz-Holbeck J; Cao JD; Gridley DS
Anticancer Res; 1999; 19(4B):2917-24. PubMed ID: 10652573
[TBL] [Abstract] [Full Text] [Related]
12. Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy.
Ten Have SM; van der Lely AJ; Lamberts SW
Clin Endocrinol (Oxf); 1997 Nov; 47(5):565-70. PubMed ID: 9425396
[TBL] [Abstract] [Full Text] [Related]
